Overview of cancer in Malaysia.

The problem of cancer in Malaysia is a growing one. It is now the fourth leading cause of death among medically certified deaths. Cancer of the lung is the most common killer among malignancies. It is estimated that the annual incidence of cancer is 30 000. The majority of patients are found at a late stage of the disease. The National Cancer Control Program aims to reduce the incidence and mortality of cancer and to improve the quality of life of cancer patients. Policies encompass prevention, early diagnosis, treatment, palliative care and rehabilitation. The program for prevention includes an anti-smoking campaign and immunization of babies against hepatitis B. Papanicolaou's smear and breast self-examination are among efforts for the early detection of cancer. Public education and the promotion of healthy lifestyles have been actively carried out. Facilities for treatment and palliative care are being developed further. Networks between the public and private sectors and non-governmental organizations have been on-going. Apart from the establishment and upgrading of treatment facilities, the need for training of skilled staff in the treatment of cancer is highlighted.

[1]  N. Najib,et al.  Imported malaria: a retrospective study in University Hospital, Kuala Lumpur, a ten-year experience. , 1998, The Medical journal of Malaysia.

[2]  L. Hooi,et al.  A hospital based study of cancer admissions. , 1998, The Medical journal of Malaysia.

[3]  H. A. Karim The elderly in Malaysia: demographic trends. , 1997, The Medical journal of Malaysia.

[4]  Adjuvant chemotherapy for colorectal cancer: a Malaysian experience. , 1997, The Medical journal of Malaysia.

[5]  I. Yaacob,et al.  Lung cancer in Kelantan. , 1990, The Medical journal of Malaysia.

[6]  M. R. Haron,et al.  Ondansetron against metoclopramide/dexamethasone--a comparative study. , 1994, The Medical journal of Malaysia.

[7]  Kathryn Flynn,et al.  Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. , 1995, The New England journal of medicine.